company background image
1MRK logo

Merck KGaA BIT:1MRK Stock Report

Last Price

€144.45

Market Cap

€62.7b

7D

2.7%

1Y

-3.0%

Updated

21 Jan, 2025

Data

Company Financials +

Merck KGaA

BIT:1MRK Stock Report

Market Cap: €62.7b

1MRK Stock Overview

Operates as a science and technology company in Germany. More details

1MRK fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Trading at 51.2% below our estimate of its fair value

Earnings are forecast to grow 10.34% per year

Analysts in good agreement that stock price will rise by 27.3%

Risk Analysis

No risks detected for 1MRK from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Merck KGaA Competitors

Recordati Industria Chimica e Farmaceutica

BIT:REC

€11.3b

Chugai Pharmaceutical

TSE:4519

JP¥10.8t

GSK

LSE:GSK

UK£55.4b

Zoetis

NYSE:ZTS

US$74.8b

Price History & Performance

Summary of share price highs, lows and changes for Merck KGaA
Historical stock prices
Current Share Price€144.45
52 Week High€176.30
52 Week Low€128.00
Beta0.72
1 Month Change4.60%
3 Month Change-9.29%
1 Year Change-2.96%
3 Year Change-23.12%
5 Year Change22.16%
Change since IPO55.83%

Recent News & Updates

Recent updates

Shareholder Returns

1MRKIT PharmaceuticalsIT Market
7D2.7%-2.1%3.4%
1Y-3.0%-5.5%16.2%

Return vs Industry: 1MRK exceeded the Italian Pharmaceuticals industry which returned -5.5% over the past year.

Return vs Market: 1MRK underperformed the Italian Market which returned 16.2% over the past year.

Price Volatility

Is 1MRK's price volatile compared to industry and market?
1MRK volatility
1MRK Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement4.3%
10% most volatile stocks in IT Market7.6%
10% least volatile stocks in IT Market2.6%

Stable Share Price: 1MRK has not had significant price volatility in the past 3 months compared to the Italian market.

Volatility Over Time: 1MRK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
166862,255Belen Garijo Lopezwww.merckgroup.com/en

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Merck KGaA Fundamentals Summary

How do Merck KGaA's earnings and revenue compare to its market cap?
1MRK fundamental statistics
Market cap€62.74b
Earnings (TTM)€2.70b
Revenue (TTM)€20.96b

23.3x

P/E Ratio

3.0x

P/S Ratio

Is 1MRK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1MRK income statement (TTM)
Revenue€20.96b
Cost of Revenue€8.64b
Gross Profit€12.33b
Other Expenses€9.63b
Earnings€2.70b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 06, 2025

Earnings per share (EPS)6.20
Gross Margin58.80%
Net Profit Margin12.86%
Debt/Equity Ratio37.8%

How did 1MRK perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

36%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 01:12
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Merck KGaA is covered by 60 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Gerhard SchwarzBaader Helvea Equity Research
Odile RundquistBaader Helvea Equity Research